Commodore Capital LP Merus N.V. Transaction History
Commodore Capital LP
- $1.12 Billion
- Q2 2024
A detailed history of Commodore Capital LP transactions in Merus N.V. stock. As of the latest transaction made, Commodore Capital LP holds 3,200,000 shares of MRUS stock, worth $164 Million. This represents 16.98% of its overall portfolio holdings.
Number of Shares
3,200,000
Previous 4,360,000
26.61%
Holding current value
$164 Million
Previous $196 Million
3.56%
% of portfolio
16.98%
Previous 16.96%
Shares
11 transactions
Others Institutions Holding MRUS
# of Institutions
194Shares Held
59.2MCall Options Held
345KPut Options Held
222K-
Rtw Investments, LP New York, NY4.17MShares$214 Million4.12% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.75MShares$141 Million3.41% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.4MShares$123 Million0.34% of portfolio
-
Samlyn Capital, LLC New York, NY2.32MShares$119 Million2.45% of portfolio
-
Franklin Resources Inc San Mateo, CA2.11MShares$108 Million0.04% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.35B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...